National lung cancer screening program feasibility study in Estonia
Abstract OBJECTIVES The main aim of the lung cancer screening (LCS) feasibility study was to investigate the plausibility of and bottlenecks to systematic enrolment in family physician practices by evaluating all their patients. METHODS In 3 family physician practices, for each individual born in 19...
Saved in:
| Published in: | Interdisciplinary cardiovascular and thoracic surgery Vol. 36; no. 6 |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
England
Oxford University Press
01.06.2023
Oxford Publishing Limited (England) |
| Subjects: | |
| ISSN: | 2753-670X, 2753-670X |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Abstract
OBJECTIVES
The main aim of the lung cancer screening (LCS) feasibility study was to investigate the plausibility of and bottlenecks to systematic enrolment in family physician practices by evaluating all their patients.
METHODS
In 3 family physician practices, for each individual born in 1947–1966 (target age group 55–74 years), information on ever smoking was gathered by a family physician/nurse. All current and ex-smokers were invited to an ‘LCS visit’. In parallel, 2 inclusion criteria were used: (1) current smoker (≥20 pack-years) or ex-smoker (quit <15 years ago and smoking history ≥20 pack-years) and (2) PLCOm2012noRace risk score >1.5. All individuals with elevated lung cancer risk were assigned low-dose computed tomography.
RESULTS
Among the total 7035 individuals in the 3 family physician practices, the LCS target age group comprised 1208 individuals, including 649 (46.3–57.1%) males and 559 (42.9–53.7%) females. Of the 1208 applicable age group individuals, 395 (all current or ex-smokers) were invited to the ‘LCS visit’. According to either 1 or both the LCS inclusion criteria, 206 individuals were referred to low-dose computed tomography, and 201 (97.6% of those referred) ended up taking it. The estimated participation rate in LCS, based on data from our feasibility study, would have been 87.4%.
CONCLUSIONS
In LCS, systematic enrolment of individuals by family physicians results in high uptake, and thus, effectiveness of the LCS in the setting of a well-functioning family physician system like in Estonia. Also, the feasibility study provided excellent input to the currently ongoing regional LCS pilot study in Estonia.
Lung cancer screening (LCS), using low-dose computed tomography (LDCT), has been proved to reduce mortality in 2 large, randomized controlled studies: National Lung Cancer Screening Trial (NLST) in the USA and Dutch-Belgian Randomized Lung Cancer Screening Trial (Dutch acronym: NELSON) in Europe [1, 2]. |
|---|---|
| AbstractList | The main aim of the lung cancer screening (LCS) feasibility study was to investigate the plausibility of and bottlenecks to systematic enrolment in family physician practices by evaluating all their patients.OBJECTIVESThe main aim of the lung cancer screening (LCS) feasibility study was to investigate the plausibility of and bottlenecks to systematic enrolment in family physician practices by evaluating all their patients.In 3 family physician practices, for each individual born in 1947-1966 (target age group 55-74 years), information on ever smoking was gathered by a family physician/nurse. All current and ex-smokers were invited to an 'LCS visit'. In parallel, 2 inclusion criteria were used: (1) current smoker (≥20 pack-years) or ex-smoker (quit <15 years ago and smoking history ≥20 pack-years) and (2) PLCOm2012noRace risk score >1.5. All individuals with elevated lung cancer risk were assigned low-dose computed tomography.METHODSIn 3 family physician practices, for each individual born in 1947-1966 (target age group 55-74 years), information on ever smoking was gathered by a family physician/nurse. All current and ex-smokers were invited to an 'LCS visit'. In parallel, 2 inclusion criteria were used: (1) current smoker (≥20 pack-years) or ex-smoker (quit <15 years ago and smoking history ≥20 pack-years) and (2) PLCOm2012noRace risk score >1.5. All individuals with elevated lung cancer risk were assigned low-dose computed tomography.Among the total 7035 individuals in the 3 family physician practices, the LCS target age group comprised 1208 individuals, including 649 (46.3-57.1%) males and 559 (42.9-53.7%) females. Of the 1208 applicable age group individuals, 395 (all current or ex-smokers) were invited to the 'LCS visit'. According to either 1 or both the LCS inclusion criteria, 206 individuals were referred to low-dose computed tomography, and 201 (97.6% of those referred) ended up taking it. The estimated participation rate in LCS, based on data from our feasibility study, would have been 87.4%.RESULTSAmong the total 7035 individuals in the 3 family physician practices, the LCS target age group comprised 1208 individuals, including 649 (46.3-57.1%) males and 559 (42.9-53.7%) females. Of the 1208 applicable age group individuals, 395 (all current or ex-smokers) were invited to the 'LCS visit'. According to either 1 or both the LCS inclusion criteria, 206 individuals were referred to low-dose computed tomography, and 201 (97.6% of those referred) ended up taking it. The estimated participation rate in LCS, based on data from our feasibility study, would have been 87.4%.In LCS, systematic enrolment of individuals by family physicians results in high uptake, and thus, effectiveness of the LCS in the setting of a well-functioning family physician system like in Estonia. Also, the feasibility study provided excellent input to the currently ongoing regional LCS pilot study in Estonia.CONCLUSIONSIn LCS, systematic enrolment of individuals by family physicians results in high uptake, and thus, effectiveness of the LCS in the setting of a well-functioning family physician system like in Estonia. Also, the feasibility study provided excellent input to the currently ongoing regional LCS pilot study in Estonia. Abstract OBJECTIVES The main aim of the lung cancer screening (LCS) feasibility study was to investigate the plausibility of and bottlenecks to systematic enrolment in family physician practices by evaluating all their patients. METHODS In 3 family physician practices, for each individual born in 1947–1966 (target age group 55–74 years), information on ever smoking was gathered by a family physician/nurse. All current and ex-smokers were invited to an ‘LCS visit’. In parallel, 2 inclusion criteria were used: (1) current smoker (≥20 pack-years) or ex-smoker (quit <15 years ago and smoking history ≥20 pack-years) and (2) PLCOm2012noRace risk score >1.5. All individuals with elevated lung cancer risk were assigned low-dose computed tomography. RESULTS Among the total 7035 individuals in the 3 family physician practices, the LCS target age group comprised 1208 individuals, including 649 (46.3–57.1%) males and 559 (42.9–53.7%) females. Of the 1208 applicable age group individuals, 395 (all current or ex-smokers) were invited to the ‘LCS visit’. According to either 1 or both the LCS inclusion criteria, 206 individuals were referred to low-dose computed tomography, and 201 (97.6% of those referred) ended up taking it. The estimated participation rate in LCS, based on data from our feasibility study, would have been 87.4%. CONCLUSIONS In LCS, systematic enrolment of individuals by family physicians results in high uptake, and thus, effectiveness of the LCS in the setting of a well-functioning family physician system like in Estonia. Also, the feasibility study provided excellent input to the currently ongoing regional LCS pilot study in Estonia. Lung cancer screening (LCS), using low-dose computed tomography (LDCT), has been proved to reduce mortality in 2 large, randomized controlled studies: National Lung Cancer Screening Trial (NLST) in the USA and Dutch-Belgian Randomized Lung Cancer Screening Trial (Dutch acronym: NELSON) in Europe [1, 2]. The main aim of the lung cancer screening (LCS) feasibility study was to investigate the plausibility of and bottlenecks to systematic enrolment in family physician practices by evaluating all their patients. In 3 family physician practices, for each individual born in 1947-1966 (target age group 55-74 years), information on ever smoking was gathered by a family physician/nurse. All current and ex-smokers were invited to an 'LCS visit'. In parallel, 2 inclusion criteria were used: (1) current smoker (≥20 pack-years) or ex-smoker (quit <15 years ago and smoking history ≥20 pack-years) and (2) PLCOm2012noRace risk score >1.5. All individuals with elevated lung cancer risk were assigned low-dose computed tomography. Among the total 7035 individuals in the 3 family physician practices, the LCS target age group comprised 1208 individuals, including 649 (46.3-57.1%) males and 559 (42.9-53.7%) females. Of the 1208 applicable age group individuals, 395 (all current or ex-smokers) were invited to the 'LCS visit'. According to either 1 or both the LCS inclusion criteria, 206 individuals were referred to low-dose computed tomography, and 201 (97.6% of those referred) ended up taking it. The estimated participation rate in LCS, based on data from our feasibility study, would have been 87.4%. In LCS, systematic enrolment of individuals by family physicians results in high uptake, and thus, effectiveness of the LCS in the setting of a well-functioning family physician system like in Estonia. Also, the feasibility study provided excellent input to the currently ongoing regional LCS pilot study in Estonia. OBJECTIVES The main aim of the lung cancer screening (LCS) feasibility study was to investigate the plausibility of and bottlenecks to systematic enrolment in family physician practices by evaluating all their patients. METHODS In 3 family physician practices, for each individual born in 1947–1966 (target age group 55–74 years), information on ever smoking was gathered by a family physician/nurse. All current and ex-smokers were invited to an ‘LCS visit’. In parallel, 2 inclusion criteria were used: (1) current smoker (≥20 pack-years) or ex-smoker (quit <15 years ago and smoking history ≥20 pack-years) and (2) PLCOm2012noRace risk score >1.5. All individuals with elevated lung cancer risk were assigned low-dose computed tomography. RESULTS Among the total 7035 individuals in the 3 family physician practices, the LCS target age group comprised 1208 individuals, including 649 (46.3–57.1%) males and 559 (42.9–53.7%) females. Of the 1208 applicable age group individuals, 395 (all current or ex-smokers) were invited to the ‘LCS visit’. According to either 1 or both the LCS inclusion criteria, 206 individuals were referred to low-dose computed tomography, and 201 (97.6% of those referred) ended up taking it. The estimated participation rate in LCS, based on data from our feasibility study, would have been 87.4%. CONCLUSIONS In LCS, systematic enrolment of individuals by family physicians results in high uptake, and thus, effectiveness of the LCS in the setting of a well-functioning family physician system like in Estonia. Also, the feasibility study provided excellent input to the currently ongoing regional LCS pilot study in Estonia. Lung cancer screening (LCS), using low-dose computed tomography (LDCT), has been proved to reduce mortality in 2 large, randomized controlled studies: National Lung Cancer Screening Trial (NLST) in the USA and Dutch-Belgian Randomized Lung Cancer Screening Trial (Dutch acronym: NELSON) in Europe [1, 2]. |
| Author | Kallavus, Kadi Makke, Vahur Rätsep, Anneli Laisaar, Tanel Takker, Urmas Poola, Anneli Laisaar, Kaja-Triin Taur, Merily Kiudma, Tarvo Viiklepp, Piret Frik, Marianna |
| Author_xml | – sequence: 1 givenname: Kadi orcidid: 0000-0002-9768-4327 surname: Kallavus fullname: Kallavus, Kadi email: kadi.kallavus@ut.ee – sequence: 2 givenname: Kaja-Triin surname: Laisaar fullname: Laisaar, Kaja-Triin – sequence: 3 givenname: Anneli surname: Rätsep fullname: Rätsep, Anneli – sequence: 4 givenname: Tarvo surname: Kiudma fullname: Kiudma, Tarvo – sequence: 5 givenname: Urmas surname: Takker fullname: Takker, Urmas – sequence: 6 givenname: Anneli surname: Poola fullname: Poola, Anneli – sequence: 7 givenname: Vahur surname: Makke fullname: Makke, Vahur – sequence: 8 givenname: Marianna surname: Frik fullname: Frik, Marianna – sequence: 9 givenname: Piret surname: Viiklepp fullname: Viiklepp, Piret – sequence: 10 givenname: Merily surname: Taur fullname: Taur, Merily – sequence: 11 givenname: Tanel surname: Laisaar fullname: Laisaar, Tanel |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36807427$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkc9rHCEcxaWkdNM0x17DQC65TOOPcdRTCMumCSztpYXcxHF04zKrG3UW9r-P3d2EbaD0IIp-vo_ne5_BiQ_eAPAVwW8ICnLt9Cana7dRPWzQB3CKGSV1y-DjydF5As5TWkIIscAEEf4JTEjLIWswOwXTHyq74NVQDaNfVFp5bWKVdDTGu3KxjmER1aqyRiXXucHlbZXy2G8r56tZysE79QV8tGpI5vywn4Hfd7Nf0_t6_vP7w_R2XuumEbnmrTa8E4haBWmrDIfC9Loti3edwIILS22Pe4wsE7DHFHFNWiwoFdQ01pIzcLPXXY_dqowZn6Ma5Dq6lYpbGZSTf7949yQXYSMRxEy0FBaFq4NCDM-jSVmuXNJmGJQ3YUwSM8YFK8Gxgl6-Q5dhjCWoJAkSiONGNKRQF8eW3ry8BlwAsgd0DClFY6V2eRd5ceiGYk3-aVLumpSHJstU_W7qVfhf_OFfYVz_B30Bz9exqw |
| CitedBy_id | crossref_primary_10_2340_1651_226X_2025_43093 crossref_primary_10_1186_s13244_024_01814_5 |
| Cites_doi | 10.3390/cancers14092343 10.2147/CMAR.S293877 10.1002/ijc.32486 10.1136/esmoopen-2019-000577 10.21037/tlcr-20-700 10.1001/jama.2021.1117 10.1016/j.jtcvs.2012.05.060 10.1097/00000421-198212000-00014 10.1016/j.jtho.2015.09.009 10.1111/resp.13963 10.1056/NEJMoa1911793 10.1183/09031936.00208714 10.1038/s41533-021-00246-8 10.1164/rccm.201408-1475OC 10.21037/jtd.2020.03.66 10.3322/caac.21660 10.1007/s00330-020-06727-7 10.1016/j.jncc.2021.07.006 10.1183/13993003.00483-2022 10.1136/thoraxjnl-2015-207140 10.21037/tlcr.2019.03.09 10.1016/j.chest.2021.06.063 10.1016/j.jtho.2020.08.006 10.1164/rccm.201905-0946OC 10.1136/thoraxjnl-2016-209825 10.1056/NEJMoa1102873 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2023. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. 2023 The Author(s) 2023. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. The Author(s) 2023. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: The Author(s) 2023. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. 2023 – notice: The Author(s) 2023. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. – notice: The Author(s) 2023. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | TOX AAYXX CITATION NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM |
| DOI | 10.1093/icvts/ivad041 |
| DatabaseName | Oxford Journals Open Access Collection CrossRef PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials - QC ProQuest Central ProQuest One ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest One Academic ProQuest One Academic ProQuest Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef PubMed Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic PubMed Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: TOX name: Oxford Journals Open Access Collection url: https://academic.oup.com/journals/ sourceTypes: Publisher – sequence: 3 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| EISSN | 2753-670X |
| ExternalDocumentID | PMC10279650 36807427 10_1093_icvts_ivad041 10.1093/icvts/ivad041 |
| Genre | Journal Article |
| GeographicLocations | Estonia |
| GeographicLocations_xml | – name: Estonia |
| GrantInformation_xml | – fundername: National Institute for Health Development – fundername: ; |
| GroupedDBID | 0R~ ABEJV ABGNP ABXVV ALMA_UNASSIGNED_HOLDINGS EMOBN IAO IHR INH ITC M~E RPM SV3 TOX 7X7 88E 8FI 8FJ AAFWJ AAYXX ABUWG AFFHD AFKRA AFPKN BENPR CCPQU CITATION FYUFA GROUPED_DOAJ HMCUK M1P PHGZM PHGZT PIMPY PJZUB PPXIY PSQYO ROL UKHRP NPM 3V. 7XB 8FK AZQEC DWQXO K9. PKEHL PQEST PQQKQ PQUKI PRINS 7X8 5PM |
| ID | FETCH-LOGICAL-c449t-86ce8b915fa056ae809edc6edc8bb92989f5fd2d21f790d2518c36295595e4ff3 |
| IEDL.DBID | BENPR |
| ISICitedReferencesCount | 6 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001015310900002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2753-670X |
| IngestDate | Tue Nov 04 02:06:45 EST 2025 Fri Sep 05 06:59:55 EDT 2025 Tue Oct 07 07:02:39 EDT 2025 Wed Feb 19 02:17:43 EST 2025 Sat Nov 29 03:37:14 EST 2025 Tue Nov 18 20:47:50 EST 2025 Wed Apr 02 07:03:57 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Keywords | Screening Feasibility Lung cancer Low-dose computed tomography |
| Language | English |
| License | This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. https://creativecommons.org/licenses/by/4.0 The Author(s) 2023. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c449t-86ce8b915fa056ae809edc6edc8bb92989f5fd2d21f790d2518c36295595e4ff3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0002-9768-4327 |
| OpenAccessLink | https://www.proquest.com/docview/3191824943?pq-origsite=%requestingapplication% |
| PMID | 36807427 |
| PQID | 3191824943 |
| PQPubID | 7215301 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_10279650 proquest_miscellaneous_2778977537 proquest_journals_3191824943 pubmed_primary_36807427 crossref_citationtrail_10_1093_icvts_ivad041 crossref_primary_10_1093_icvts_ivad041 oup_primary_10_1093_icvts_ivad041 |
| PublicationCentury | 2000 |
| PublicationDate | 2023-06-01 |
| PublicationDateYYYYMMDD | 2023-06-01 |
| PublicationDate_xml | – month: 06 year: 2023 text: 2023-06-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: Oxford |
| PublicationTitle | Interdisciplinary cardiovascular and thoracic surgery |
| PublicationTitleAlternate | Interdiscip Cardiovasc Thorac Surg |
| PublicationYear | 2023 |
| Publisher | Oxford University Press Oxford Publishing Limited (England) |
| Publisher_xml | – name: Oxford University Press – name: Oxford Publishing Limited (England) |
| References | Quaife (2023062002545846800_ivad041-B20) 2020; 201 Burzic (2023062002545846800_ivad041-B15) 2022; 14 Coughlin (2023062002545846800_ivad041-B28) 2020; 12 Crosbie (2023062002545846800_ivad041-B16) 2022; 60 Infante (2023062002545846800_ivad041-B23) 2015; 191 Aberle (2023062002545846800_ivad041-B1) 2011; 365 Mazzone (2023062002545846800_ivad041-B7) 2021; 160 2023062002545846800_ivad041-B11 Bartlett (2023062002545846800_ivad041-B30) 2021; 31 Estonian Health Insurance Fund (2023062002545846800_ivad041-B12) 2021 American College of Radiology (2023062002545846800_ivad041-B17) Paci (2023062002545846800_ivad041-B21) 2017; 72 Pasquinelli (2023062002545846800_ivad041-B14) 2020; 15 Sung (2023062002545846800_ivad041-B18) 2021; 71 Field (2023062002545846800_ivad041-B25) 2016; 71 Kauczor (2023062002545846800_ivad041-B4) 2020; 30 Marshall (2023062002545846800_ivad041-B26) 2015; 45 Jaklitsch (2023062002545846800_ivad041-B5) 2012; 144 Rzyman (2023062002545846800_ivad041-B10) 2019; 8 Rankin (2023062002545846800_ivad041-B24) 2020; 25 Oken (2023062002545846800_ivad041-B13) 1982; 5 Goldstraw (2023062002545846800_ivad041-B19) 2016; 11 Lee (2023062002545846800_ivad041-B27) 2021; 10 Becker (2023062002545846800_ivad041-B22) 2020; 146 Li (2023062002545846800_ivad041-B29) 2021; 1 Field (2023062002545846800_ivad041-B3) 2019; 4 de Koning (2023062002545846800_ivad041-B2) 2020; 382 Krist (2023062002545846800_ivad041-B6) 2021; 325 van Meerbeeck (2023062002545846800_ivad041-B8) 2022; 14 Lung Cancer Early Detection Program (2023062002545846800_ivad041-B9) |
| References_xml | – volume: 14 start-page: 2343 year: 2022 ident: 2023062002545846800_ivad041-B8 article-title: Lung cancer screening: new perspective and challenges in Europe publication-title: Cancers (Basel) doi: 10.3390/cancers14092343 – volume: 14 start-page: 637 year: 2022 ident: 2023062002545846800_ivad041-B15 article-title: The future of lung cancer screening: current challenges and research priorities publication-title: Cancer Manag Res doi: 10.2147/CMAR.S293877 – volume: 146 start-page: 1503 year: 2020 ident: 2023062002545846800_ivad041-B22 article-title: Lung cancer mortality reduction by LDCT screening—results from the randomized German LUSI trial publication-title: Int J Cancer doi: 10.1002/ijc.32486 – volume: 4 start-page: e000577 year: 2019 ident: 2023062002545846800_ivad041-B3 article-title: Implementation of lung cancer screening in Europe: challenges and potential solutions: summary of a multidisciplinary roundtable discussion publication-title: ESMO Open doi: 10.1136/esmoopen-2019-000577 – volume: 10 start-page: 723 year: 2021 ident: 2023062002545846800_ivad041-B27 article-title: Feasibility of implementing a national lung cancer screening program: interim results from the Korean Lung Cancer Screening Project (K-LUCAS) publication-title: Transl Lung Cancer Res doi: 10.21037/tlcr-20-700 – volume: 325 start-page: 962 year: 2021 ident: 2023062002545846800_ivad041-B6 article-title: Screening for lung cancer: US preventive services task force recommendation statement publication-title: J Am Med Assoc doi: 10.1001/jama.2021.1117 – volume: 144 start-page: 33 year: 2012 ident: 2023062002545846800_ivad041-B5 article-title: The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups publication-title: J Thorac Cardiovasc Surg doi: 10.1016/j.jtcvs.2012.05.060 – volume: 5 start-page: 649 year: 1982 ident: 2023062002545846800_ivad041-B13 article-title: Toxicity and response criteria of the Eastern Cooperative Oncology Group publication-title: Am J Clin Oncol doi: 10.1097/00000421-198212000-00014 – volume: 11 start-page: 39 year: 2016 ident: 2023062002545846800_ivad041-B19 article-title: The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM Classification for lung cancer publication-title: J Thorac Oncol doi: 10.1016/j.jtho.2015.09.009 – volume: 25 start-page: 5 year: 2020 ident: 2023062002545846800_ivad041-B24 article-title: Lung cancer screening implementation: complexities and priorities publication-title: Respirology doi: 10.1111/resp.13963 – volume: 382 start-page: 503 year: 2020 ident: 2023062002545846800_ivad041-B2 article-title: Reduced lung-cancer mortality with volume CT screening in a randomized trial publication-title: N Engl J Med doi: 10.1056/NEJMoa1911793 – volume: 45 start-page: 1734 year: 2015 ident: 2023062002545846800_ivad041-B26 article-title: Lung cancer screening feasibility in Australia publication-title: Eur Respir J doi: 10.1183/09031936.00208714 – ident: 2023062002545846800_ivad041-B17 – volume: 31 start-page: 36 year: 2021 ident: 2023062002545846800_ivad041-B30 article-title: Implications of incidental findings from lung screening for primary care: data from a UK pilot publication-title: NPJ Prim Care Respir Med doi: 10.1038/s41533-021-00246-8 – volume: 191 start-page: 1166 year: 2015 ident: 2023062002545846800_ivad041-B23 article-title: Long-term follow-up results of the DANTE trial, a randomized study of lung cancer screening with spiral computed tomography publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.201408-1475OC – volume: 12 start-page: 2536 year: 2020 ident: 2023062002545846800_ivad041-B28 article-title: Understanding barriers to lung cancer screening in primary care publication-title: J Thorac Dis doi: 10.21037/jtd.2020.03.66 – volume: 71 start-page: 209 year: 2021 ident: 2023062002545846800_ivad041-B18 article-title: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries publication-title: CA Cancer J Clin doi: 10.3322/caac.21660 – volume: 30 start-page: 3277 year: 2020 ident: 2023062002545846800_ivad041-B4 article-title: ESR/ERS statement paper on lung cancer screening publication-title: Eur Radiol doi: 10.1007/s00330-020-06727-7 – volume: 1 start-page: 132 year: 2021 ident: 2023062002545846800_ivad041-B29 article-title: Results of the cancer screening feasibility study in China: a multicentered randomized controlled trial of lung and colorectal cancer screening publication-title: J Natl Cancer Center doi: 10.1016/j.jncc.2021.07.006 – volume: 60 start-page: 2200483 year: 2022 ident: 2023062002545846800_ivad041-B16 article-title: Participation in community-based lung cancer screening: the Yorkshire Lung Screening Trial publication-title: Eur Respir J doi: 10.1183/13993003.00483-2022 – year: 2021 ident: 2023062002545846800_ivad041-B12 – ident: 2023062002545846800_ivad041-B9 – volume: 71 start-page: 161 year: 2016 ident: 2023062002545846800_ivad041-B25 article-title: UK Lung Cancer RCT pilot screening trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening publication-title: Thorax doi: 10.1136/thoraxjnl-2015-207140 – volume: 8 start-page: S95 year: 2019 ident: 2023062002545846800_ivad041-B10 article-title: Implementation of lung cancer screening at the national level: Polish example publication-title: Transl Lung Cancer Res doi: 10.21037/tlcr.2019.03.09 – volume: 160 start-page: e427–94 year: 2021 ident: 2023062002545846800_ivad041-B7 article-title: Screening for lung cancer: CHEST guideline and expert panel report publication-title: Chest doi: 10.1016/j.chest.2021.06.063 – volume: 15 start-page: 1738 year: 2020 ident: 2023062002545846800_ivad041-B14 article-title: Risk prediction model versus United States preventive services task force lung cancer screening eligibility criteria: reducing race disparities publication-title: J Thorac Oncol doi: 10.1016/j.jtho.2020.08.006 – volume: 201 start-page: 965 year: 2020 ident: 2023062002545846800_ivad041-B20 article-title: Lung Screen Uptake Trial (LSUT): randomized controlled clinical trial testing targeted invitation materials publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.201905-0946OC – volume: 72 start-page: 825 year: 2017 ident: 2023062002545846800_ivad041-B21 article-title: Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial publication-title: Thorax doi: 10.1136/thoraxjnl-2016-209825 – ident: 2023062002545846800_ivad041-B11 – volume: 365 start-page: 395 year: 2011 ident: 2023062002545846800_ivad041-B1 article-title: Reduced lung-cancer mortality with low-dose computed tomographic screening publication-title: N Engl J Med doi: 10.1056/NEJMoa1102873 |
| SSID | ssj0002923138 |
| Score | 2.262424 |
| Snippet | Abstract
OBJECTIVES
The main aim of the lung cancer screening (LCS) feasibility study was to investigate the plausibility of and bottlenecks to systematic... The main aim of the lung cancer screening (LCS) feasibility study was to investigate the plausibility of and bottlenecks to systematic enrolment in family... OBJECTIVES The main aim of the lung cancer screening (LCS) feasibility study was to investigate the plausibility of and bottlenecks to systematic enrolment in... Lung cancer screening (LCS), using low-dose computed tomography (LDCT), has been proved to reduce mortality in 2 large, randomized controlled studies: National... |
| SourceID | pubmedcentral proquest pubmed crossref oup |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| SubjectTerms | Age groups Feasibility studies Lung cancer Medical screening Thoracic Oncology Tomography |
| Title | National lung cancer screening program feasibility study in Estonia |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/36807427 https://www.proquest.com/docview/3191824943 https://www.proquest.com/docview/2778977537 https://pubmed.ncbi.nlm.nih.gov/PMC10279650 |
| Volume | 36 |
| WOSCitedRecordID | wos001015310900002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2753-670X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0002923138 issn: 2753-670X databaseCode: DOA dateStart: 20220101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2753-670X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0002923138 issn: 2753-670X databaseCode: M~E dateStart: 20230101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVASL databaseName: Oxford Journals Open Access Collection customDbUrl: eissn: 2753-670X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0002923138 issn: 2753-670X databaseCode: TOX dateStart: 20230101 isFulltext: true titleUrlDefault: https://academic.oup.com/journals/ providerName: Oxford University Press – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 2753-670X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0002923138 issn: 2753-670X databaseCode: 7X7 dateStart: 20220101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 2753-670X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0002923138 issn: 2753-670X databaseCode: BENPR dateStart: 20220101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 2753-670X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0002923138 issn: 2753-670X databaseCode: PIMPY dateStart: 20220101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NS8MwFA86PXjxA7-mc0QQT5a1TbomJ1GZKOgcojJPpUkTLIxO1znwv_elzeomqAcPLYSENul7yfvl5fX3EDoSseKeCFxAbpQ4VLe5I9xYOIx62iMalKgI-X-6Cbtd1u_znnW45TascromFgt1MpTGR94CVQEoTDklp69vjskaZU5XbQqNRbRkmMpAz5fOO93efeVl8Q1-IcySa8LuvZXKyThvpZM4cak3Z4zmfnCbwZnfwyVn7M_l2n97vo5WLfLEZ6WqbKAFlW2iC8uLPcADmPVYGh0YYVhKYHsLRg3b8C2sVWzjaD9wwUiL0wx3DHBM4y30eNl5uLhybF4FR1LKxw5rS8UE9wIdA_yJFXM5DK4NFxOCG0p2HejET3xPh9xNAAExCXbOcNUFimpNtlEtG2ZqF8HbpUjAyDHJBZjDgLvETwJuUB2RMtB1dDL9wJG0pOMm98UgKg-_SVTII7LyqKPjqvlrybbxU8NDkNZfbRpTeUR2YubRlzDgEVU1TClzThJnavieR34YMoDFAQnraKcUffUm0jbsQT7UsDmlqBoYuu75mix9KWi7AcqFHADx3u_92kcrJqV9GY7WQLXx6F0doGUYWZqPmmgx7IfFnTWtsjcLPwKUete3vWcoPdz1PwG-SA_5 |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Nb9QwEB2VLRJcoIivhVKMBJyINrGdjX2oEOqHuup2tYeCyinEji0irbJlsy3qn-I3dpw4aRep9NQDh5xs2U7meebFHj8DvFeZkZGKQ2RunAXcDmWgwkwFgkc2YhZBVKf8fxsnk4k4OZHTNfjTnoVxaZWtT6wddT7Xbo18gFBBKswlZ59PfwXu1ii3u9peodHA4tBc_MZftmp7tIv2_UDp_t7xzkHgbxUINOdyGYihNkLJKLYZBv_MiFCaXA_xEUpJJ0huY5vTnEY2kWGO8V9o9PJOqS023FqG7d6DdY5gD3uwPh0dTb93qzrU8SUmvJhnKNmg0OfLalCcZ3nIo5Xgt3Kg7hqv_Ts981q823_8v32pDXjkmTX50kyFJ7Bmyqew43W_Z2SGXo1oh_EFQVeJv-8YtIlPTyPWZD5P-ILUirukKMmeI8ZF9gy-3sm4n0OvnJfmJWDvWuUYxIWWCsN9LENG81g61sq0jm0fPrUGTbUXVXd3e8zSZnOfpbX9U2__Pnzsqp82aiI3VXyH6LitzmZr_9Q7niq9Mj420RWjy3D7QFlp5mdVSpNEIO2PWdKHFw3Uup7Y0KkjUSwRKyDsKjg58tWSsvhZy5IjVU0kEv5X_x7XW3hwcHw0TsejyeFreEiRNDapd5vQWy7OzBu4j29ZVIstP7kI_LhrlF4CqrxoWA |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=National+lung+cancer+screening+program+feasibility+study+in+Estonia&rft.jtitle=Interdisciplinary+cardiovascular+and+thoracic+surgery&rft.au=Kallavus%2C+Kadi&rft.au=Laisaar%2C+Kaja-Triin&rft.au=R%C3%A4tsep%2C+Anneli&rft.au=Kiudma%2C+Tarvo&rft.date=2023-06-01&rft.issn=2753-670X&rft.eissn=2753-670X&rft.volume=36&rft.issue=6&rft_id=info:doi/10.1093%2Ficvts%2Fivad041&rft.externalDBID=n%2Fa&rft.externalDocID=10_1093_icvts_ivad041 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2753-670X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2753-670X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2753-670X&client=summon |